LPixel Announces Participation at 2019 HIMSS Global Conference & Exhibition
Tokyo, Japan – January 29, 2019 – LPixel, a leader in image analysis and processing technology in life science and medical research, is proud to announce its attendance at HIMSS Global Conference and Exhibition scheduled to take place in Orlando, Florida from February 11, 2019 to February 15, 2019. Headquartered in Chicago and hosted annually, HIMSS promotes networking opportunities, the latest in technologies, and the best use of IT and management systems in the healthcare industry.
LPixel is also pleased to announce that the Head of North America Business, Dr. Partha P. Paul, will be speaking about LPixel’s AI-powered medical image diagnostic support solutions at the Innovation Live. LPixel would like to take this opportunity to invite attendees to visit the company’s booth to learn about the latest in its medical AI technologies.
・Date: Monday, February 11, 2019 to Friday, February 15, 2019 (Booth exhibition from February 12-14)
・Place: Orange County Convention Center, Innovation Live Booth #9000-08
・Featured Service: AI Medical Image Diagnostic Support Technology, EIRL
Title: AI for Medical Image Diagnosis
Presenter: Partha P. Paul (Head of North America Business)
Date/Time: Wednesday, February 13, 3:45 pm – 4:05 pm
Place: Innovation Live Hall F, Booth 9000
EIRL is the collective name given to LPixel’s AI-based medical image diagnostic support technology. LPixel has implemented EIRL in the ongoing research and development of various areas of medical image diagnostics, such as MRI scans of the brain and breasts, chest X-rays, colonoscopy and pathology. Moving forward, LPixel will continue to amplify its research and development efforts, and aim to use EIRL in medical applications after performing the necessary procedures in accordance with the applicable laws and regulations. Details here: https://eirl.ai
Founded in March 2014, LPixel is a University of Tokyo spin-off that hones its expertise in life science image analysis. LPixel unifies artificial intelligence and its image analysis technologies to develop and provide advanced software for researchers and professionals in the life science industry, including the medical, pharmaceutical and agricultural sectors. LPixel is currently working in collaboration with the University of Tokyo, the National Cancer Center Japan and other research institutions to further the development of its AI-powered medical diagnosis technology. For more information, please visit https://lpixel.net/en/